SYTL5 promotes papillary thyroid carcinoma progression by enhancing activation of the NF-κB signaling pathway.
Sign Up to like & getrecommendations! Published in 2022 at "Endocrinology"
DOI: 10.1210/endocr/bqac187
Abstract: The function and mechanism of SYTL5 in papillary thyroid carcinoma (PTC) are still unclear. In this research, we found that SYTL5 was significantly overexpressed in PTC tissues compared with normal thyroid tissues. SYTL5 downregulation significantly… read more here.
Keywords: thyroid carcinoma; signaling pathway; progression; sytl5 ... See more keywords